Westlake Corporation
WLK
$112.61
-5.37%
Westlake Corporation is a vertically integrated international manufacturer and marketer of performance and essential materials, such as olefins and polyethylene, and housing and infrastructure products, operating within the specialty chemicals industry. The company is a significant player with a vertically integrated model that provides cost and supply chain advantages across its two core segments. The current investor narrative is heavily focused on the company's operational performance amid volatile commodity prices, as recent news highlights broad-based supply shocks in chemicals and materials due to geopolitical tensions, which directly impact input costs and end-market demand for Westlake's products.…
WLK
Westlake Corporation
$112.61
Investment Opinion: Should I buy WLK Today?
Rating: Hold. The core thesis is that WLK is a deeply cyclical stock caught between a powerful technical recovery rally and still-deteriorating fundamentals, making it too risky to buy but too strong to sell outright.
The stock's primary valuation metric, a PS ratio of 0.85x, sits at the absolute bottom of its multi-year range and suggests extreme pessimism is priced in. However, this is justified by a -10.9% YoY revenue decline and a catastrophic gross margin of -17.25% in Q4. The technical picture is compelling, with 3-month returns of 42.27% vastly outperforming the market, but this momentum is disconnected from the negative free cash flow and ROE of -17.15%. Analyst sentiment is mixed but includes a recent upgrade, though specific target prices are unavailable to quantify implied upside.
The thesis would upgrade to a Buy if the company demonstrates a clear inflection in gross margin (back to positive territory) and a sequential improvement in revenue, signaling the cyclical trough is in. It would downgrade to a Sell if the next quarterly report shows continued cash burn and losses while the stock remains near its 52-week highs, confirming the rally is unsustainable. Relative to its own history, the stock is undervalued on a sales basis, but relative to its current profitability, it remains expensive as it is loss-making. The verdict is a Hold for risk-tolerant investors betting on a cycle turn, but a clear avoid for those seeking stability or income.
Sign up to view all
WLK 12-Month Price Forecast
The outlook for WLK is bifurcated between its cheap valuation/strong momentum and its terrible fundamentals. The base case of a volatile range trade is most probable, as the market digests whether the recent rally is a false dawn. The stock is a pure play on the timing and strength of a cyclical recovery in specialty chemicals and housing. The stance would upgrade to Bullish on concrete evidence of margin recovery (gross margin >5%) and a halt in revenue declines. It would downgrade to Bearish if the next earnings report shows the Q4 collapse was not a one-time inventory event but the start of a new norm of losses.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Westlake Corporation's 12-month outlook, with a consensus price target around $146.39 and implied upside of +30.0% versus the current price.
Average Target
$146.39
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$90 - $146
Analyst target range
A cohort of 8 analysts provides coverage, with recent institutional ratings showing a mix of Buy, Neutral, and Outperform calls, including an upgrade from BMO Capital to Outperform in early March, indicating a generally constructive but cautious stance. The average target price and specific Buy/Hold/Sell distribution are not provided in the dataset, preventing calculation of implied upside or a clear consensus view; however, the presence of multiple recent ratings from major firms suggests ongoing institutional interest and debate around the stock's trajectory amid the challenging fundamental backdrop.
Bulls vs Bears: WLK Investment Factors
The investment debate for Westlake is a classic clash between deep-value technical momentum and catastrophic near-term fundamentals. The bull case, currently supported by the powerful price action, rests on the stock trading at a multi-year low valuation (0.85x PS) and the market anticipating a cyclical recovery in chemicals and housing. The bear case, grounded in hard financial data, highlights a company in severe distress with collapsing margins, negative cash flow, and accelerating revenue declines. The single most important tension is whether the current technical breakout represents a prescient discounting of an imminent fundamental recovery, or a speculative rally that will falter when the next set of poor earnings is reported. The bear side currently has stronger evidence from the company's own financial statements, but the market's violent repricing cannot be ignored.
Bullish
- Deep Value Price-to-Sales Ratio: WLK trades at a trailing PS ratio of 0.85x, a severe discount to its own historical range which was above 3.5x as recently as late 2024. This suggests the market has priced in extreme pessimism, creating a potential margin of safety if fundamentals stabilize.
- Powerful Technical Momentum: The stock is up 42.27% over the past three months and 36.09% over the past year, significantly outperforming the S&P 500. It trades at 95% of its 52-week high ($124.23), indicating strong buying pressure and a breakout from its lows near $56.
- Analyst Upgrade & Constructive Stance: BMO Capital upgraded WLK to Outperform in early March, and a cohort of 8 analysts provides coverage. This institutional interest, amidst severe fundamental headwinds, suggests a belief in a cyclical recovery narrative.
- Strong Balance Sheet Liquidity: The company maintains a current ratio of 2.24 and a manageable debt-to-equity ratio of 0.73. This financial flexibility provides a buffer to weather the current downturn without immediate solvency concerns.
Bearish
- Severe Profitability Collapse: Q4 2025 results show a catastrophic net loss of $544 million and a gross margin of -17.25%, a sharp deterioration from Q3's gross profit of $236 million. This indicates acute margin compression and potential inventory writedowns.
- Accelerating Revenue Decline: Revenue fell 10.9% YoY in Q4, worsening from an 8.8% decline in Q3. This deepening cyclical downturn signals persistent weakness in core end markets like housing and infrastructure.
- Negative Free Cash Flow & ROE: The company burned $530 million in free cash flow over the TTM and has a Return on Equity of -17.15%. This demonstrates it is consuming cash and destroying shareholder value in the current environment.
- Commodity Supply Shock Risk: Recent news highlights a broad-based commodity supply shock from geopolitical tensions, directly impacting chemicals. This creates immediate price and margin pressure on WLK's inputs and outputs, threatening any nascent recovery.
WLK Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 36.09% over the past year and currently trading at approximately 95% of its 52-week high of $124.23, indicating strong momentum and proximity to a key resistance level. Recent momentum has been exceptionally strong, with the stock up 10.60% over the past month and 42.27% over the past three months, significantly outpacing the S&P 500's returns of 0.46% and -2.1% over the same periods, respectively, which signals accelerating bullish momentum. Key technical levels are the 52-week high of $124.23 as immediate resistance and the 52-week low of $56.33 as major support; a confirmed breakout above resistance would signal a continuation of the uptrend, while the stock's beta of 0.748 indicates it has been about 25% less volatile than the broader market during this advance.
Beta
0.75
0.75x market volatility
Max Drawdown
-47.6%
Largest decline past year
52-Week Range
$56-$124
Price range past year
Annual Return
+22.6%
Cumulative gain past year
| Period | WLK Return | S&P 500 |
|---|---|---|
| 1m | +0.0% | +7.4% |
| 3m | +28.2% | +2.7% |
| 6m | +49.6% | +6.9% |
| 1y | +22.6% | +34.9% |
| ytd | +51.9% | +4.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WLK Fundamental Analysis
Revenue is under significant pressure, with Q4 2025 revenue of $2.53 billion representing an 10.9% year-over-year decline, and the trend has worsened sequentially from a 8.8% YoY drop in Q3, indicating a deepening cyclical downturn in its end markets. Profitability has collapsed, with the company reporting a net loss of $544 million and a gross margin of -17.25% in Q4, a severe deterioration from a gross profit of $236 million in Q3, highlighting acute margin compression and potential inventory writedowns amid falling selling prices. The balance sheet shows a current ratio of 2.24 and a debt-to-equity ratio of 0.73, indicating adequate short-term liquidity, but financial health is strained by negative free cash flow of $530 million over the trailing twelve months and a negative Return on Equity of -17.15%, signaling the company is consuming cash and destroying shareholder value in the current environment.
Quarterly Revenue
$2.5B
2025-12
Revenue YoY Growth
-0.10%
YoY Comparison
Gross Margin
-0.17%
Latest Quarter
Free Cash Flow
$-530000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WLK Overvalued?
Given the negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 0.85x, which is a significant discount to its own historical PS band, which has ranged above 3.5x as recently as late 2024, suggesting the market is pricing in severe fundamental deterioration. Peer comparison data is not available in the provided dataset, preventing a sector premium/discount analysis. The current PS of 0.85x sits near the absolute bottom of the stock's multi-year historical range, which typically signals either a deep value opportunity or a market expectation of sustained revenue declines and poor future profitability, consistent with the recent quarterly losses.
PE
-6.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -80x~526x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-66.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company is reporting massive losses, with a Q4 net loss of $544 million and a gross margin of -17.25%, indicating it is selling products below cost. This is compounded by negative free cash flow of $530 million over the TTM, which strains liquidity despite a solid current ratio of 2.24. Revenue is in a clear downtrend, falling 10.9% YoY in the latest quarter, showing high sensitivity to the economic cycle in housing and infrastructure. The negative ROE of -17.15% confirms shareholder value is being destroyed at the current operational run-rate.
Market & Competitive Risks center on valuation compression and external shocks. While the PS ratio of 0.85x is cheap historically, it could compress further if revenue continues to fall. The stock's 42% surge in 3 months, while the S&P 500 fell 2.1%, creates vulnerability to a sector rotation out of cyclical winners. The recent news of a commodity supply shock from geopolitical conflict is a direct threat, likely to increase input cost volatility and squeeze margins further for a company already in a loss-making position. The low beta of 0.748 offers little comfort if company-specific fundamentals deteriorate.
Worst-Case Scenario involves a prolonged cyclical downturn exacerbated by sustained high input costs from geopolitical tensions, leading to consecutive quarters of deep losses. This could erode the balance sheet, force asset sales, and lead to a dividend cut (current yield 2.85%). The realistic downside is significant; a return to the 52-week low of $56.33 from the current price of $118.37 represents a loss of approximately -52%. This level was tested as recently as November 2025 and reflects a price where the market priced in near-insolvency fears. A break below this support could trigger a further decline towards book value, implying additional downside.
FAQ
The key risks are, in order of severity: 1) Fundamental Collapse Risk: The company is reporting massive losses (-$544M in Q4) and burning cash ($530M TTM FCF), which could weaken its balance sheet. 2) Cyclical Downturn Risk: Revenue is declining at an accelerating rate (-10.9% YoY), tied directly to weak housing and infrastructure markets. 3) Commodity Price Risk: As a chemical manufacturer, it is exposed to input cost volatility, exacerbated by geopolitical supply shocks per recent news. 4) Momentum Reversal Risk: The stock's 42% 3-month rally is starkly disconnected from fundamentals, creating vulnerability to a sharp correction if the next earnings disappoint.
The 12-month forecast is highly scenario-dependent. The base case (50% probability) sees the stock trading between $95 and $115 as it consolidates recent gains amid a slow, choppy recovery. The bull case (30% probability) projects a breakout above the 52-week high toward $124-$140, driven by a faster-than-expected return to profitability. The bear case (20% probability) warns of a drop back to the $56-$75 range if losses persist and the cyclical downturn deepens. The most likely outcome is the base case, which assumes the company's financials stabilize but do not dramatically improve in the near term.
WLK is both undervalued and overvalued, depending on the metric. On a Price-to-Sales basis, it is deeply undervalued at 0.85x, trading at the very bottom of its multi-year historical range which was above 3.5x. This suggests the market is pricing in sustained poor performance. However, on an earnings basis, it is overvalued as it is loss-making, with a negative trailing PE ratio. The forward PE of 30.9x, based on analyst EPS estimates, is high for a cyclical company, implying the market expects a sharp earnings recovery. Overall, the stock is fairly valued for the current state of its business cycle but undervalued relative to its long-term average, creating potential if a recovery materializes.
WLK is a high-risk, high-potential-reward stock that is not a good buy for most investors. For aggressive investors specializing in cyclical turnarounds, it may offer an attractive entry point due to its historically low Price-to-Sales ratio of 0.85x and powerful technical momentum (up 42% in 3 months). However, the severe fundamental deterioration—including a Q4 net loss of $544 million and negative free cash flow—makes it a speculative bet. It could be a good buy only for those who have high conviction in an imminent recovery in the chemicals and housing sectors and can tolerate the risk of the stock re-testing its 52-week low of $56.33, a -52% drop from current levels.
WLK is unsuitable for short-term trading due to its cyclical nature and high fundamental uncertainty; its low beta of 0.748 also suggests it is not a high-volatility trading vehicle. It is a candidate for a medium- to long-term investment (minimum 2-3 years) for investors betting on a full industry cycle recovery. The investment thesis is predicated on the company navigating the trough and eventually returning to the profitability levels seen in 2024, which is a multi-quarter process. Given the lack of a reliable dividend (payout ratio is negative) and current earnings volatility, it is not an income stock. It is purely a speculative capital appreciation play on an economic cycle turn.
